TherapeuticsMD Inc. (TXMD)
TXMD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.96
-2.97% on the day
Market cap
$22.7M
Nano cap
Revenue · 2024
$1.8M
+35.3% on 2023
Net income · 2024
-$2.2M
-123.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | TXMD on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000025743 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $1.8M |
| Net income | -$2.2M |
| Operating income | -$6.1M |
| Net margin | -123.9% |
| Operating margin | -347.1% |
| Revenue growth | +35.3% |
| Cash | $5.1M |
| Total assets | $38.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 12.9× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | POS AM | 2022-03-24 |
| Latest annual report ANNUAL REPORT | 10-K/A | 2026-04-01 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-11 |
| Latest current report CURRENT REPORT | 8-K | 2026-08-11 |
| Latest proxy PROXY STATEMENT | DEFA14A | 2025-11-03 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| KYNB | Kyntra Bio Inc. | $5.87 | -4.08% | $23.8M |
| AYTU | Aytu BioPharma Inc. | $1.99 | +1.01% | $21.6M |
| UPC | Universe Pharmaceuticals Inc. | $4.27 | +3.39% | $21.5M |
| PBM | Psyence Biomedical Ltd. Common Shares | $4.55 | -4.01% | $24.2M |
| QNTM | Quantum Biopharma Ltd. Class B Subordinate Voting Shares | $2.89 | +2.48% | $24.5M |
| SHPH | Shuttle Pharmaceuticals Holdings Inc. | $5.18 | -4.95% | $24.7M |
| COCP | Cocrystal Pharma Inc. | $1.08 | +1.89% | $20.8M |
| BYSI | BeyondSpring Inc. | $0.6067 | -1.43% | $24.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier